NCT02155647
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02155647
Title Avelumab in Subjects With Merkel Cell Carcinoma (JAVELIN Merkel 200)
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors EMD Serono
Indications
Therapies
Age Groups: adult
Covered Countries USA | ITA | FRA | ESP | DEU | AUS

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field